| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 99.077 | 133.547 | 152.762 | 285.080 | 274.295 | 366.317 | 427.626 | 435.418 | 489.330 | 499.432 |
| Total Income - EUR | 99.092 | 133.583 | 152.762 | 285.080 | 274.319 | 366.407 | 427.793 | 435.535 | 489.495 | 499.563 |
| Total Expenses - EUR | 48.221 | 86.137 | 100.299 | 192.325 | 164.582 | 172.659 | 181.389 | 235.604 | 304.575 | 266.658 |
| Gross Profit/Loss - EUR | 50.872 | 47.445 | 52.463 | 92.755 | 109.737 | 193.748 | 246.403 | 199.931 | 184.920 | 232.905 |
| Net Profit/Loss - EUR | 42.732 | 43.392 | 42.454 | 89.904 | 106.994 | 190.084 | 242.125 | 196.260 | 180.121 | 219.258 |
| Employees | 5 | 6 | 4 | 5 | 4 | 4 | 5 | 7 | 8 | 4 |
Check the financial reports for the company - Diabet Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 924 | 185.641 | 177.192 | 151.263 | 132.379 | 114.308 | 99.908 | 104.345 | 207.154 | 467.016 |
| Current Assets | 47.568 | 22.399 | 29.952 | 92.053 | 87.586 | 229.225 | 209.065 | 193.659 | 219.682 | 115.093 |
| Inventories | 3.315 | 4.419 | 14.202 | 8.604 | 427 | 2.014 | 3.218 | 32.374 | 32.276 | 0 |
| Receivables | 3.006 | 570 | 775 | 1.397 | 9.550 | 4.201 | 5.098 | 5.114 | 27.159 | 5.448 |
| Cash | 41.247 | 17.410 | 14.975 | 82.052 | 77.609 | 223.010 | 200.749 | 156.171 | 160.248 | 109.644 |
| Shareholders Funds | 72 | 71 | 70 | 69 | 67 | 66 | 65 | 196.325 | 375.851 | 439.821 |
| Social Capital | 72 | 71 | 70 | 69 | 67 | 66 | 65 | 65 | 65 | 64 |
| Debts | 48.420 | 208.207 | 207.074 | 243.247 | 219.898 | 343.467 | 315.055 | 102.246 | 51.551 | 142.851 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabet Med Srl